HERPES VIRUS INFECTIONS: PATHOGENESIS, CLINICAL MANIFESTATIONS, AND MANAGEMENT
Abstract
This article provides a comprehensive overview of herpes virus infections, focusing on their epidemiology, pathogenesis, clinical manifestations, diagnostic methods, treatment strategies, and preventive measures. Herpes viruses, belonging to the Herpesviridae family, are characterized by their ability to establish lifelong latent infection and reactivate under certain conditions. The article discusses the clinical significance of Herpes Simplex Virus types 1 and 2, Varicella-Zoster Virus, and other members of the Herpesviridae family. Emphasis is placed on antiviral therapy, recurrence management, psychosocial implications, and public health strategies to reduce the spread of herpes infections. The study aims to enhance understanding of herpes pathophysiology and support improved patient care and preventive measures.
References
1. Whitley, R. J., & Roizman, B. (2001). Herpes simplex viruses. In Fields Virology (4th ed., pp. 2461–2509). Philadelphia: Lippincott Williams & Wilkins.
2. Looker, K. J., Garnett, G. P., & Schmid, D. S. (2008). An estimate of the global prevalence and incidence of herpes simplex virus type 1 infection. Bulletin of the World Health Organization, 86(10), 805–812.
3. James, C., & Kimberlin, D. W. (2015). Herpes simplex virus. In D. K. Murray & S. R. Long (Eds.), Viral Infections in Humans (pp. 143–162). Springer.
4. Fatahzadeh, M., & Schwartz, R. A. (2007). Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. Journal of the American Academy of Dermatology, 57(5), 737–763.
5. Cohen, J. I. (2015). Herpesvirus latency. Journal of Clinical Investigation, 125(12), 4743–4751.
6. Arvin, A. (1996). Varicella-zoster virus. Clinical Microbiology Reviews, 9(3), 361–381.
7. Wald, A., & Corey, L. (2007). Persistence in herpes simplex virus infection: mechanisms and consequences. Current Opinion in Microbiology, 10(4), 428–434.
8. Stanberry, L. R., & Cunningham, A. L. (2004). Prospects for control of herpes simplex virus infections: vaccines, antivirals, and immune therapy. Expert Review of Vaccines, 3(6), 823–837.
